Du har inte javascript påslaget. Det innebär att många funktioner inte fungerar. För mer information om Vinnova, ta kontakt med oss.

Tailored QMS framework for innovative consumable reagent kit to comply with cell and gene therapy companies

Diarienummer
Koordinator Countagen AB
Bidrag från Vinnova 200 000 kronor
Projektets löptid januari 2024 - augusti 2024
Status Pågående
Utlysning Medtech4Health: kompetensförstärkning i småföretag
Ansökningsomgång Medtech4Health: Kompetensförstärkning i småföretag 2023

Syfte och mål

In this project, we aim to set up a customized quality management system (QMS) framework to ensure our quality and consistently deliver products that meet customers’ expectations while complying with relevant quality regulations. This strategic development in collaboration with PlantVision will be key to achieve our vision to become the gold standard for gene editing analysis by meeting industry standards for cell and gene therapy companies. The aim is to implement a QMS framework that follows and will support ISO 13485 which are relevant for the targeted market segment.

Förväntade effekter och resultat

This strategic development in collaboration with PlantVision will be key to achieve our vision to become the gold standard for gene editing analysis by meeting industry standards for cell and gene therapy companies. The aim is to implement a QMS framework that follows and will support ISO 13485 which are relevant for the targeted market segment.

Planerat upplägg och genomförande

QMS roadmap and strategy: 1. Needs analysis - a needs analysis is performed in form of a workshop. 2. Scope identification - the delivery manager of the project compiles the results of the workshop and makes an assessment of the most favorable strategy. 3. Project definition -a list of prioritized Standard operating procedures (SOP) are presented. 4. Issue review and approve documents - The SOPs are written. 5. Follow up - are done with company representatives. 6. Training - a specific training session are held for the whole company. 7. Hand over

Texten på den här sidan har projektgruppen själv formulerat. Innehållet är inte granskat av våra redaktörer.

Senast uppdaterad 20 februari 2024

Diarienummer 2023-04001

Statistik för sidan